Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving

NCT01466361 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01466361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01466361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2010
Completion date
December 31, 2010
Enrollment
187 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking, smoking cessation